DTPA- 1- hydroxy- 3- aminopropane- 1,1- diphosphonate

evaluated as a rat myocardial infarct model; structure given in first source

Also Known As:

1-hydroxy-3-aminopropane 1,1-diphosphonate-Gd-DTPA; Gd-DTPA-HPDP; GdDTPA-HPDP

Networked: 1 relevant articles (1 outcomes, 0 trials/studies)

1.	Infarction (Infarctions) 04/01/1993 - "The specificity of Gd-DTPA-HPDP for soft-tissue calcification and its retention within the infarcts permitted imaging at 1 to 2 h postinjection, (after unbound material has cleared the normal tissues). " 04/01/1993 - "Gd-DTPA-HPDP permits a more accurate infarct delineation than is possible with the unmodified agent."
2.	Myocardial Infarction 04/01/1993 - "The agent, 1-hydroxy-3-aminopropane-1,1-diphosphonate-modified-Gd-DTPA (Gd-DTPA-HPDP) accumulates in two models of myocardial infarction, (i.e., drug-induced diffusely infarcted whole hearts and in focal acute myocardial infarction from a left coronary artery ligation). "

1.	Ligation